Skip to main content
. 2021 Jan 20;18(3):868. doi: 10.3390/ijerph18030868

Table 4.

Association between obesity and chronic diseases among respondents (N = 1380).

Characteristics Obese Non-Obese Chi-Square Crude OR (95%CI) p Value
Chronic disease 19.00 <0.001 * (0.117)
Yes 87 (26.8%) 238 (73.2%) 1.92 (1.43–2.56)
No 169 (16.0%) 886 (84.0%)
Heart disease 0.25 0.620
Yes 6 (22.2%) 21 (77.8%) 1.26 (0.50–3.16)
No 250 (18.5%) 1103 (81.5%)
Diabetes 10.37 0.001 * (0.087)
Yes 33 (30.0%) 77 (70.0%) 2.01 (1.31–3.10)
No 223 (17.6%) 1047 (82.4%)
Stroke 0.20 0.546 a
Yes 1 (12.5%) 7 (87.5%) 0.63 (0.08–5.11)
No 255 (18.6%) 1117 (81.4%)
Hypertension 22.80 <0.001 * (0.129)
Yes 52 (32.3%) 109 (67.7%) 2.37 (1.65–3.41)
No 204 (16.7%) 1015 (83.3%)
Arthritis 2.72 0.099
Yes 10 (29.4%) 24 (70.6%) 1.86 (0.88–3.95)
No 246 (18.3%) 1100 (81.7%)
Cancer 0.69 0.408 a
Yes 0 (0.0%) 3 (100.0%) -
No 256 (18.6%) 1121 (81.4%)
Asthma 3.99 0.046 * (0.054)
Yes 20 (27.4%) 53 (72.6%) 1.71 (1.00–2.92)
No 236 (18.1%) 1071 (81.9%)
Kidney Failure 0.56 0.499
Yes 0 (0.0%) 2 (100.0%)
No 256 (18.6%) 1122 (81.4%)
Thyroidism 5.27 0.043 a,* (0.062)
Yes 4 (50.0%) 4 (50.0%) 4.44 (1.10–17.89)
No 252 (18.4%) 1120 (81.6%)

* significant at p < 0.05. () is the measure of significant association (2 × 2 for phi coefficient and others for contingency coefficient), using Guildford’s rule of thumb to interpret the magnitude of association between the two variables. a = Fisher’s Exact Test.